482 related articles for article (PubMed ID: 10755606)
1. The T-type calcium channel blocker mibefradil reduced interstitial and perivascular fibrosis and improved hemodynamic parameters in myocardial infarction-induced cardiac failure in rats.
Sandmann S; Bohle RM; Dreyer T; Unger T
Virchows Arch; 2000 Feb; 436(2):147-57. PubMed ID: 10755606
[TBL] [Abstract][Full Text] [Related]
2. Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats.
Sandmann S; Claas R; Cleutjens JP; Daemen MJ; Unger T
J Cardiovasc Pharmacol; 2001 Jan; 37(1):64-77. PubMed ID: 11152376
[TBL] [Abstract][Full Text] [Related]
3. Effects of the calcium channel antagonist mibefradil on haemodynamic parameters and myocardial Ca(2+)-handling in infarct-induced heart failure in rats.
Sandmann S; Min JY; Meissner A; Unger T
Cardiovasc Res; 1999 Oct; 44(1):67-80. PubMed ID: 10615391
[TBL] [Abstract][Full Text] [Related]
4. Effects of the calcium channel antagonist mibefradil on haemodynamic and morphological parameters in myocardial infarction-induced cardiac failure in rats.
Sandmann S; Spitznagel H; Chung O; Xia QG; Illner S; Jänichen G; Rossius B; Daemen MJ; Unger T
Cardiovasc Res; 1998 Aug; 39(2):339-50. PubMed ID: 9798519
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cardioprotective effects of mibefradil and ramipril in stroke-prone spontaneously hypertensive rats.
Xia QG; Reinecke A; Dorenkamp M; Storz C; Bitterling H; Penz S; Cleutjens J; Daemen MJ; Simon R; Unger T
Acta Pharmacol Sin; 2004 Jun; 25(6):763-8. PubMed ID: 15169629
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction.
Min JY; Sandmann S; Meissner A; Unger T; Simon R
J Pharmacol Exp Ther; 1999 Dec; 291(3):1038-44. PubMed ID: 10565822
[TBL] [Abstract][Full Text] [Related]
7. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.
Tao ZW; Huang YW; Xia Q; Xu QW
Chin Med J (Engl); 2005 Jan; 118(2):146-54. PubMed ID: 15667801
[TBL] [Abstract][Full Text] [Related]
8. Long-acting calcium channel antagonist pranidipine prevents ventricular remodeling after myocardial infarction in rats.
Takeuchi K; Omura T; Yoshiyama M; Yoshida K; Otsuka R; Shimada Y; Ujino K; Yoshikawa J
Heart Vessels; 1999; 14(3):111-9. PubMed ID: 10776803
[TBL] [Abstract][Full Text] [Related]
9. Effects of endothelin ETA receptor blocker LU 135252 on cardiac remodeling and survival in a hypertensive rat model of chronic heart failure.
Xia QG; Reinecke A; Dorenkamp M; Daemen MJ; Simon R; Unger T
Acta Pharmacol Sin; 2006 Nov; 27(11):1417-22. PubMed ID: 17049116
[TBL] [Abstract][Full Text] [Related]
10. [Effects of perindopril on left ventricular remodeling and myocardial osteopontin expression in rats with myocardial infarction].
Zhang YL; Zhou SX; Wang MH; Wang JF
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1584-8. PubMed ID: 17121705
[TBL] [Abstract][Full Text] [Related]
11. Calcium channel blockade limits transcriptional, translational and functional up-regulation of the cardiac calpain system after myocardial infarction.
Sandmann S; Spormann J; Prenzel F; Shaw L; Unger T
Eur J Pharmacol; 2002 Oct; 453(1):99-109. PubMed ID: 12393065
[TBL] [Abstract][Full Text] [Related]
12. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of beta-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: importance of timing of treatment and infarct size.
Hu K; Gaudron P; Ertl G
J Am Coll Cardiol; 1998 Mar; 31(3):692-700. PubMed ID: 9502655
[TBL] [Abstract][Full Text] [Related]
14. Effects of a novel angiotensin AT(1) receptor antagonist, HR720, on rats with myocardial infarction.
Xia QG; Chung O; Spitznagel H; Sandmann S; Illner S; Rossius B; Jähnichen G; Reinecke A; Gohlke P; Unger T
Eur J Pharmacol; 1999 Dec; 385(2-3):171-9. PubMed ID: 10607873
[TBL] [Abstract][Full Text] [Related]
15. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH
Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.
Sandmann S; Li J; Fritzenkötter C; Spormann J; Tiede K; Fischer JW; Unger T
Blood Press; 2006; 15(2):116-28. PubMed ID: 16754275
[TBL] [Abstract][Full Text] [Related]
17. Significance of timing of angiotensin AT1 receptor blockade in rats with myocardial infarction-induced heart failure.
Xia QG; Chung O; Spitznagel H; Illner S; Jänichen G; Rossius B; Gohlke P; Unger T
Cardiovasc Res; 2001 Jan; 49(1):110-7. PubMed ID: 11121802
[TBL] [Abstract][Full Text] [Related]
18. Effects of mibefradil, a T- and L-type calcium channel blocker, on cardiac remodeling in the UM-X7.1 cardiomyopathic hamster.
Villame J; Massicotte J; Jasmin G; Dumont L
Cardiovasc Drugs Ther; 2001 Jan; 15(1):41-8. PubMed ID: 11504162
[TBL] [Abstract][Full Text] [Related]
19. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
20. The ACE 2 activator diminazene aceturate (DIZE) improves left ventricular diastolic dysfunction following myocardial infarction in rats.
Castardeli C; Sartório CL; Pimentel EB; Forechi L; Mill JG
Biomed Pharmacother; 2018 Nov; 107():212-218. PubMed ID: 30092400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
